FOXO1 re-expression with a dual-recombinase allele rescues class switching in germinal center B cells
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20241136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Carlota Farré Díaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany. Hauptthemen laut MEDLINE: Germinal Center, B-Lymphocytes, Forkhead Box Protein O1, Immunoglobulin Class Switching. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Deutsche Krebshilfe, Berlin School of Integrative Oncology.
Abstract (Originalsprache)
Modeling complex (patho)physiological processes by sequential targeted mutagenesis in mice is limited by the lack of precision of cellular targeting and complex breeding strategies. We present a new Cre/DreERT2 dual-recombinase germinal center B cell (GCBC)–specific strain, with co-expression of the recombinases from a single allele. This enables highly efficient Cre-mediated FOXO1 knockout in GCBCs in vivo, followed by time-controlled, efficient Dre-mediated FOXO1 re-expression in the same cells, leading to functional rescue of GC compartmentalization and class switch recombination. The present approach can be easily adapted to other cellular contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.
- Biology of Malignant Lymphomas, Max Delbrück Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.
- Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and the Charité - Universitätsmedizin Berlin , Berlin, Germany.
- Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin , Berlin, Germany.
- Genome Diversification & Integrity, Max Delbrück Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.
- Core Unit Bioinformatics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin and Berlin Institute of Health , Berlin, Germany.
ORCID-Profile: Carlota Farré Díaz, Eleni Kabrani, Wiebke Winkler, Eric Blanc, Brigitte Wollert-Wulf, Claudia Salomon, F Thomas Wunderlich, Dieter Beule, Martin Janz, Klaus Rajewsky
Förderung
- European Research Council
- Deutsche Krebshilfe
- Berlin School of Integrative Oncology
- Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
Zitieren
APA
Farré Díaz, C., Kabrani, E., Winkler, W., Blanc, E., Wollert-Wulf, B., Salomon, C., Wunderlich, F. T., Beule, D., Janz, M., & Rajewsky, K. (2026). FOXO1 re-expression with a dual-recombinase allele rescues class switching in germinal center B cells. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20241136
Vancouver
Farré Díaz C, Kabrani E, Winkler W, Blanc E, Wollert-Wulf B, Salomon C, et al. FOXO1 re-expression with a dual-recombinase allele rescues class switching in germinal center B cells. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20241136
BibTeX
@article{FarrDaz2026,
author = {Farré Díaz, Carlota and Kabrani, Eleni and Winkler, Wiebke and Blanc, Eric and Wollert-Wulf, Brigitte and Salomon, Claudia and Wunderlich, F Thomas and Beule, Dieter and Janz, Martin and Rajewsky, Klaus},
title = {FOXO1 re-expression with a dual-recombinase allele rescues class switching in germinal center B cells},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20241136}
}
EUVIMED